08:00 , Jan 25, 2016 |  BioCentury  |  Emerging Company Profile

Mining ALS possibilities

Treeway B.V. was co-founded by two amyotrophic lateral sclerosis patients to develop a series of therapies that over time could turn the degenerative disease into a chronic, manageable condition. In the near term, the company...
07:00 , Aug 3, 2015 |  BC Week In Review  |  Company News

Amarna Therapeutics, CBMed deal

Amarna and CBmed partnered to develop immunotherapies to treat acute lymphoblastic leukemia (ALL), obesity, Type II diabetes and atherosclerotic cardiovascular disease. Amarna will provide its SVac viral gene delivery vector platform, and CBmed will perform...